Shares of The Cigna Group (NYSE:CI – Get Free Report) gapped down prior to trading on Thursday after the company announced weaker than expected quarterly earnings. The stock had previously closed at ...

Cigna Group closed 20.66% short of its 52-week high of $370.83, which the company reached on September 16th.

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

With all the hype around AI, business partners and legal professionals are scrambling to understand, adapt, and possibly implement the ...

The general mood among these heavyweight investors is divided, with 41% leaning bullish and 41% bearish. Among these notable options, 3 are puts, totaling $371,983, and 9 are calls, amounting to ...

Cigna Group inc. (NYSE: CI) shares are rebounding Friday after dropping on Thursday following a fourth-quarter earnings miss.

The villains were injectable specialty drugs like Keytruda and inpatient surgical procedures for seriously ill patients.

Raymond James analyst John Ransom lowered the firm’s price target on Cigna (CI) to $360 from $415 and keeps a Strong Buy rating on the shares.

CEO David Cordani suggested Thursday that the moves are a direct response to the slaying of UnitedHealthcare CEO Brian Thompson and the public outcry over the state of health care. Other news is on ...

The number of victims impacted by the Change Healthcare data breach last year has nearly doubled, from 100 million to ...

Q4 2024 Earnings Call Transcript January 30, 2025 Cigna Corporation misses on earnings expectations. Reported EPS is $6.64 ...

Cantor Fitzgerald analyst Sarah James maintained a Buy rating on Cigna (CI – Research Report) yesterday and set a price target of $350.00. The ...